Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Felicita Andreotti, Antonino Maria Tommaso Buffon, Eliano Pio Navarese, Volker Schulze, Michalina Kolodziejczak, Marc Brouwer, Francesco Costa, Mariusz Kowalewski, Gianfranco Parati, Gregory Y. H. Lip, Malte Kelm, Marco Valgimigli

Research output: Contribution to journalArticle

235 Citations (Scopus)

Abstract

N/A
Original languageEnglish
Pages (from-to)h1618-h1618
JournalBMJ
Volume350
Publication statusPublished - 2015

Keywords

  • Aspirin
  • Combined Modality Therapy
  • Coronary Artery Disease
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Drug-Eluting Stents
  • Hemorrhage
  • Humans
  • Models, Statistical
  • Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials'. Together they form a unique fingerprint.

Cite this